Evidence map›Paper›PMID 38693040›Full record

ArticlePancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]2024

Identification of pancreatic cancer risk factors from clinical notes using natural language processing.

Dhruv Sarwal, Liwei Wang, Sonal Gandhi, Elham Sagheb Hossein Pour, Laurens P Janssens, Adriana M Delgado, Karen A Doering, Anup Kumar Mishra, Jason D Greenwood, Hongfang Liu and 1 more

Open access · greenAbstract read
In one paragraph

Article in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Dhruv SarwalDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Liwei WangDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, USA.
Sonal GandhiDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Elham Sagheb Hossein PourDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, USA.
Laurens P JanssensDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Adriana M DelgadoDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Karen A DoeringDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Anup Kumar MishraDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Jason D GreenwoodDepartment of Family Medicine, Mayo Clinic, Rochester, MN, USA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Hongfang LiuDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, USA.
Shounak MajumderDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. Electronic address: Majumder.Shounak@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic in Florida · USMayo Clinic · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic CancerU01CA210138 · NCI · MAYO CLINIC ROCHESTER · PI Shounak Majumder, Kenneth Zaret · 2016 to 2026
$9.0M
NCATS NIH HHS UL1 TR002377NCI NIH HHS U01 CA210138
6 · The paper itself

Abstract

objectivesScreening for pancreatic ductal adenocarcinoma (PDAC) is considered in high-risk individuals (HRIs) with established PDAC risk factors, such as family history and germline mutations in PDAC susceptibility genes. Accurate assessment of risk factor status is provider knowledge-dependent and requires extensive manual chart review by experts. Natural Language Processing (NLP) has shown promise in automated data extraction from the electronic health record (EHR). We aimed to use NLP for automated extraction of PDAC risk factors from unstructured clinical notes in the EHR.

methodsWe first developed rule-based NLP algorithms to extract PDAC risk factors at the document-level, using an annotated corpus of 2091 clinical notes. Next, we further improved the NLP algorithms using a cohort of 1138 patients through patient-level training, validation, and testing, with comparison against a pre-specified reference standard. To minimize false-negative results we prioritized algorithm recall.

resultsIn the test set (n = 807), the NLP algorithms achieved a recall of 0.933, precision of 0.790, and F

conclusionsRule-based NLP algorithms applied to unstructured clinical notes are highly sensitive for automated identification of PDAC risk factors. Further validation in a large primary-care patient population is warranted to assess real-world utility in identifying HRIs for pancreatic cancer screening.

Indexed as

AlgorithmsCarcinoma, Pancreatic DuctalElectronic Health RecordsNatural Language ProcessingPancreatic NeoplasmsAdultAgedCohort StudiesFemaleHumansMaleMiddle AgedRisk FactorsArtificial intelligenceCancer screeningNatural language processingPancreatic cancerPancreatic ductal adenocarcinoma

Identifiers

PMID38693040
PMCPMC12264882
OpenAlexW4393203629

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.